These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 37797781)

  • 1. The CRISPR Revolution: Unraveling the mysteries of Life's genetic code.
    Harsij Z; Ghafoorzadeh Z; Goharian E
    Gene; 2024 Jan; 892():147870. PubMed ID: 37797781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting CRISPR/Cas-mediated crop improvement: Special focus on nutrition.
    Kaul T; Sony SK; Verma R; Motelb KFA; Prakash AT; Eswaran M; Bharti J; Nehra M; Kaul R
    J Biosci; 2020; 45():. PubMed ID: 33361628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
    Bhatia S; Pooja ; Yadav SK
    Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges.
    Ahmad HI; Ahmad MJ; Asif AR; Adnan M; Iqbal MK; Mehmood K; Muhammad SA; Bhuiyan AA; Elokil A; Du X; Zhao C; Liu X; Xie S
    Curr Issues Mol Biol; 2018; 28():47-68. PubMed ID: 29428910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genome editing revolution.
    van der Oost J; Patinios C
    Trends Biotechnol; 2023 Mar; 41(3):396-409. PubMed ID: 36709094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR as a driving force: the Model T of biotechnology.
    Mariscal C; Petropanagos A
    Monash Bioeth Rev; 2016 Jun; 34(2):101-116. PubMed ID: 27619650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
    Wang L; Zheng W; Liu S; Li B; Jiang X
    Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
    Hwang S; Maxwell KL
    J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.